Lactonorm

Quick links to important sections

Lactonorm

Selected form

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lactonorm

Lactonorm is a pharmaceutical preparation classified within the group of Probiotic Agents, designed to modulate the human microbial balance. Its defining active component is the live microorganism Lactobacillus Acidophilus, which is a species of bacteria of Biological origin naturally found in the human gastrointestinal and urogenital tracts.

Property Description
Active ingredient Lactobacillus Acidophilus (Live microorganisms)
Forms Capsule, Tablet, Vaginal Suppository, Powder
Pharmacological class Probiotic Agent
General Purpose Restoration of Microbial Balance
Origin Biological

What Type of Medicine is Lactonorm?

Lactonorm is fundamentally categorized as a Probiotic Agent, a pharmacological classification relating to the strain's ability to colonize the gut. The product utilizes live microorganisms to confer a health benefit on the host, acting as an established biological approach to therapeutic support. Lactobacillus is used to improve the composition of the gut microbiota. The overall general purpose of this preparation is to support the natural balance of the intestinal or vaginal flora, which is essential for maintaining systemic health.


Composition, Forms, and General Purpose

The composition of Lactonorm is centered on the single-strain product Lactobacillus Acidophilus (INN), which are Gram-positive bacteria. The preparation is positioned for use in adults and is available in several high-level dosage forms, including oral capsules, tablets, or powder, as well as locally applied options like vaginal suppositories or vaginal tablets. The versatility in Routes of administration (Oral or Vaginal) allows for targeted delivery of the active agent to the relevant site for restoration of intestinal flora or vaginal balance.


Action: Supporting the Body's Natural Acidity

The physiological action of Lactonorm is achieved primarily through the process of Microbiota modulation. The Lactobacillus Acidophilus bacteria perform their key function by metabolizing nutrients and naturally producing lactic acid. This process supports the creation and maintenance of a vital acidic environment in the mucous membranes. This mechanism assists in the prevention of growth of harmful bacteria by making the local ecosystem less hospitable to pathogens, thereby helping the body restore its natural defenses.

Regulatory References

  1. Lactobacillus acidophilus - NCI Drug Dictionary
  2. L. acidophilus and Gut Microbiota

What side effects are possible with Lactonorm?

Possible side effects and safety information

The safety profile for Lactonorm, a probiotic agent containing Lactobacillus acidophilus, is structured by official regulatory classifications of observed adverse reactions. The effects are primarily categorized based on the organ systems involved and their documented frequency.


Adverse Reactions and Frequency Classification

Side effects documented in regulatory sources are generally localized and non-serious, frequently occurring within the Gastrointestinal disorders or Reproductive system and breast disorders System-Organ Classes.

Classification Common Adverse Reactions System-Organ Class Focus
Common Bloating, flatulence, abdominal discomfort Gastrointestinal disorders
Common (Local Forms) Mild vaginal irritation, vaginal discharge Reproductive system disorders
Incidence Not Known Severe hypersensitivity or allergic reaction Immune system disorders

Certain gastrointestinal symptoms, such as flatulence and bloating, may be noted at the initiation of therapy, typically subsiding with continued exposure.


Serious Adverse Reactions and Safety Constraints

Regulatory documents highlight the rare but serious potential for systemic infection (bacteremia or sepsis) caused by the probiotic strain. This risk is notably elevated in immunocompromised individuals or patients with central venous catheters.

This medicine is formally contraindicated in individuals with a known hypersensitivity to Lactobacillus acidophilus or any of the preparation's excipients. Safety information emphasizes monitoring for signs of systemic infection or severe allergic reactions, particularly within these defined vulnerable populations.

Overdose and Emergency Response

Lactonorm Overdose and when to seek help

Overdose Scope and Management

Lactonorm is typically available as a probiotic product containing live bacterial cultures, often Lactobacillus species, and is generally considered to have a wide safety margin. Unlike traditional pharmaceutical drugs, overdose with probiotic preparations is rarely associated with severe acute systemic toxicity or life-threatening symptoms, as the product is not absorbed systemically in high concentrations.

Documented Overdose Presentations: Over-ingestion may lead to gastrointestinal discomfort due to the volume or high concentration of organisms. Symptoms are generally limited to bloating, increased flatulence, and mild abdominal pain.

Emergency Actions: No specific antidote is required. In the event of consuming significantly more than the recommended amount, the primary action is to cease further intake and observe symptoms.

When to Seek Urgent Medical Attention

Urgent medical attention is not typically required for an isolated, accidental over-ingestion of Lactonorm. However, you should seek immediate professional medical help if, following the over-ingestion, you experience any of the following:

  • Severe, persistent, or worsening abdominal pain.
  • Difficulty breathing or signs of a serious allergic reaction (e.g., swelling of the face, tongue, or throat).
  • High fever, nausea, or vomiting that is unusual or does not resolve.
  • Any other symptoms that cause significant concern for your health or persist beyond 24 hours.

Always bring the product packaging with you when seeking medical advice.

Therapeutic Uses of Lactonorm

Lactonorm is commonly used when short-term symptomatic assistance is needed for symptoms related to systemic imbalance.

Supportive Relief for Digestive Discomfort

This product is generally used across conditions presenting with symptoms associated with acute or episodic changes in the gut. It is applied across domains where additional management of discomfort is required for groups of symptoms that may appear suddenly or fluctuate. The application is focused on addressing symptoms related to physical discomfort such as bloating, gas, and irregular bowel movements. The primary purpose is to provide support that helps ease the overall symptom burden, particularly when symptoms may intensify temporarily.

Promoting Urogenital and Vaginal Comfort

Lactonorm is considered relevant for easing symptoms that interfere with daily comfort in the urogenital domain. This is used in situations involving certain distressing symptoms, such as irritation or mild odor, in conditions involving episodic or fluctuating manifestations. This supportive application may assist with maintaining functional stability, which supports general well-being during symptomatic phases.

Quick Fact: Supportive Assistance for Digestive and Urogenital Symptoms

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Lactonorm — Official Regulatory Information

Eligibility Scope

Populations for whom use is allowed (as stated in label): Adults; Children aged 3 years and older.

Populations for whom use is contraindicated: Patients with known hypersensitivity to any ingredient are absolutely prohibited from use. Due to the inherent risk of systemic infection from the live bacteria, the preparation must not be used by immunocompromised individuals (e.g., those on chemotherapy or with severe underlying diseases). Use is also contraindicated in premature infants in hospital settings, as well as in patients with severe intestinal damage or severe acute pancreatitis.

Pregnancy and lactation eligibility status (if explicitly documented): Use is officially categorized as restricted. It is advised only under the supervision of a healthcare professional, as official labeling notes the lack of adequate human studies to determine infant risk during these periods.

Eligibility-related restrictions: Use in children under 3 years of age is not recommended without specific doctor's direction. Official monographs also state that the effects of age are not established for both pediatric and geriatric populations. Certain high-risk comorbidities, such as short bowel syndrome or damaged heart valves, necessitate additional medical oversight.


Connection to the overall eligibility profile

Official regulatory documents define eligibility based on clear contraindications that prohibit the use of this live microbial preparation in immunocompromised and other severely vulnerable groups, minimizing infection risk. The rules also establish restricted use for pregnant and breastfeeding women and minimum age thresholds, requiring specialized medical direction where patient data is insufficient.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section describes officially documented interaction patterns for Lactonorm, a probiotic agent utilizing live microorganisms.


Interaction Structure and Restrictions

Interaction Type Officially Documented Statement
Timing-Based Restriction Co-administration with Oral Antibacterial Drugs requires a mandatory time separation. To mitigate pharmacodynamic interference, the probiotic must be administered at least 2 to 3 hours before or after the dose of the antibacterial agent.
Pharmacodynamic Interference The effectiveness of the Lactobacillus Acidophilus component may be compromised by co-use with Antifungal Agents, which is documented as potential interference with the live culture.
Drug-Modified Population Risk A specific caution is documented for use in patients receiving Immunosuppressive Medicines. This addresses the regulatory concern associated with administering a live biological agent to individuals with drug-modified immune defenses.

The regulatory profile for Lactonorm is characterized by the absence of systemic interactions, confirming that no official data documents interactions involving CYP enzymes, drug transporters, or changes in systemic exposure (AUC/Cmax) with co-administered chemical drugs. No formal interaction restrictions are documented with food, alcohol, or herbal products. The entire interaction profile is strictly constrained by the viability of the live microorganism component and specific population safety considerations.

Mechanism of Action

Competitive Exclusion and Adhesion Blocking

This mechanism involves the introduced bacteria physically colonizing the epithelial surface, utilizing resources, and blocking adhesion sites on host cells. This action limits the establishment of non-native, opportunistic microbes, and contributes to the structural composition of the local microflora.

Local Environmental pH Modulation

The active bacteria metabolize available nutrients, producing lactic acid as a key byproduct. This process significantly lowers the local environmental pH equilibrium, establishing a lower local pH. This pH reduction limits the proliferation of pH-sensitive microorganisms.

Active Antimicrobial Synthesis

Beyond physical competition, the beneficial bacteria are involved in a cascade that results in the synthesis and release of specific antimicrobial substances (e.g., bacteriocins). These substances directly interfere with the structural integrity and metabolic processes of competing microbes, influencing the composition of the microbial ecosystem.

Dosage and Administration Information

How to Use Lactonorm: Administration Guidelines

This information details the method, dosage, and schedule for using Lactonorm, based on the established instructions for the product.


Administration Protocol

The use of this medicine is defined by a protocol covering the route, dosing, and duration of treatment.

Administration Scope Requirement
Route of Administration Vaginal
Dosing Schedule One capsule, twice daily, for 7 days
Age Group Rule Intended for adult women

Procedural Structure

The instructions specify a sequence of actions to ensure correct administration:

  • Insertion: Insert one capsule vaginally.
  • Frequency: Repeat the insertion of one capsule approximately 12 hours later (twice daily).
  • Duration: Continue this twice-daily regimen for the full 7-day duration, even if symptoms improve earlier.

Missed Dose Instructions

If a dose is missed, it should be administered as soon as it is remembered. The subsequent dose should then be taken at its regularly scheduled time. Do not use two capsules simultaneously to make up for a missed dose.

Use Protocol Summary

These guidelines establish a standard treatment course. The protocol specifies a vaginal route of administration, a consistent twice-daily frequency, and a 7-day duration, ensuring the medicine is used exactly as defined in the product documentation.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Studies Investigating the Drug for Chronic Pain

Multiple published studies and clinical trials have explored whether the drug was investigated for potential changes in quality of life for participants with chronic musculoskeletal pain.

According to reports from one clinical trial, researchers examined whether the drug was associated with a change in pain scores, and reported findings that included an average change of 40% in pain scores within the first week. This trial reported that the change occurred within the first week. Findings from the study described the duration over which a change in discomfort scores was observed.


Studies Investigating Combination Therapy

Research evaluated whether combining the drug with standard physical therapy was investigated in a comparative setting relative to physical therapy alone. The study reported findings regarding mobility for the combination group. Research has explored the use of this drug in individuals with pre-existing heart conditions. Long-term follow-up data was collected to evaluate whether the combination was investigated to examine the long-term observations for the study participants.

Key Studies & References Lactonorm Combined with Physical Therapy vs. Physical Therapy Alone: A Comparative Effectiveness Study

Frequently Asked Questions (FAQ)

Common questions about Lactonorm (FAQ)


Q: How quickly does Lactonorm start working?

Official information describes that Lactonorm's action, such as the colonization of beneficial bacteria and the change in local pH balance, begins shortly after administration. However, regulatory documents do not specify an exact time frame for when an individual may experience relief of symptoms, as this can vary widely among patients.


Q: Can Lactonorm be used for recurring vaginal issues?

The product is officially indicated for the treatment of conditions related to microbial imbalance. It is important to review the product's official indications to clarify if it is approved for preventative or recurrence-management use.


Q: Can I use Lactonorm while taking oral contraceptives?

According to the official product information, Lactonorm does not have a documented formal interaction with oral contraceptives. Its interaction profile is typically limited to substances that affect the viability of the live bacteria it contains.


Q: Does Lactonorm interact with common pain relievers like ibuprofen?

The regulatory profile for this medicine does not document systemic interactions. Therefore, no formal interaction with common pain relievers like ibuprofen is officially listed.


Q: Is Lactonorm safe to use during pregnancy? (Seeking general, non-personal info)

Use during pregnancy is officially categorized as restricted, meaning it is only advised under the supervision of a healthcare professional. This restriction is due to the lack of adequate and controlled studies in humans to fully assess the risk to the fetus.


Q: Can women who are breastfeeding use Lactonorm?

Similar to pregnancy, use during breastfeeding is categorized as restricted by regulatory bodies. It is recommended only under the guidance of a healthcare professional because data on the transfer of the product's components to the infant via milk are not fully established.


Q: How long after finishing a course of antibiotics can I start Lactonorm?

Official instructions mandate a time separation of at least 2 to 3 hours between administering this probiotic and taking an oral antibacterial drug. This separation is necessary to prevent the antibacterial agent from compromising the viability of the beneficial live bacteria in Lactonorm.


Q: Can Lactonorm be used with condoms or diaphragms?

Official regulatory information may contain warnings if the non-active ingredients (excipients) in the suppository base are known to compromise the material integrity of barrier contraceptives, such as latex condoms or diaphragms. Any warnings or specific guidelines regarding use with barrier contraceptives are detailed in the official product information.


Q: Can teenagers or pre-pubescent girls use Lactonorm?

The medicine is officially intended for adult women and certain children aged 3 years and older. Use for age groups not explicitly covered is not supported without specific medical oversight.


Q: Where in the vagina should Lactonorm be inserted?

The official administration instructions detail the correct usage, specifying that the capsule should be inserted vaginally. Precise technique is detailed in the official administration instructions provided with the product.


Q: Is it normal to have some discharge after using Lactonorm?

Yes, regulatory safety information documents that mild vaginal irritation and vaginal discharge are common local adverse reactions that may be noted while using this product. This may be related to the suppository base dissolving.


Q: Is Lactonorm available over the counter?

The dispensing status of Lactonorm (Prescription-Only or Over-The-Counter) is determined by the specific national regulatory authority. You can find this information in the official documentation or label provided by the manufacturer.


Q: Are there studies supporting the use of Lactonorm?

Yes, the regulatory label contains a summary of the clinical evidence and trials that support the approved therapeutic indication(s) and safety profile. This research is the basis for the product's authorization.


Q: Can men use Lactonorm for any reason?

The medicine is officially indicated for conditions specific to adult women and certain children. Use for male populations is not supported by the official labeling and indications.


Q: Does alcohol consumption affect how Lactonorm works?

According to official regulatory documents, no formal interaction restrictions are documented regarding the consumption of alcohol while using Lactonorm.


Q: What should I do if I forget to use a dose of Lactonorm?

Official instructions state that if a dose is missed, it should be administered as soon as it is remembered. It is explicitly stated that you should not use two capsules simultaneously to make up for a missed dose.


Q: Are there different strengths or formulations of Lactonorm?

Yes, official labeling confirms that Lactonorm is available in several high-level dosage forms, including oral capsules or tablets and locally applied options like vaginal suppositories or tablets.


Q: Is Lactonorm more effective when used at night?

The official dosing schedule requires a consistent twice-daily frequency. No official data is documented to suggest increased effectiveness when the medicine is specifically administered at night compared to other times during the day.


Q: What's the difference between Lactonorm capsules and suppositories?

The primary difference between these forms is their route of administration. Capsules are intended for oral use, while suppositories and tablets are formulated for local, vaginal administration.


Q: Is the sensation of a dissolving suppository normal?

The safety profile documents common local reactions, such as mild irritation or discharge. These sensations can be associated with the dissolution of the suppository base after insertion.


Q: Can Lactonorm interact with vaginal lubricants or gels?

The interaction profile is focused on maintaining the viability of the live bacteria. Substances that could compromise the viability of the bacteria are generally discouraged as they may interfere with the intended therapeutic action.


Q: What is the main mechanism by which Lactonorm prevents recurrence?

The core mechanism is stabilizing the microbial ecosystem through competitive exclusion (blocking pathogen sites), adhesion blocking, and local pH modulation. This action helps maintain a healthy environment, which is the basis for potentially preventing the re-establishment of opportunistic pathogens.


Q: Can Lactonorm be used as a preventative measure?

The product's officially approved use is strictly defined by its regulatory indication, which specifies if it is approved for primary treatment or also for prophylactic (preventative) support. Consult the official indication.


Q: What are the non-active ingredients or excipients in Lactonorm?

Official regulatory documents provide a complete list of all excipients, or non-active ingredients, that are used in the formulation alongside the active ingredient, Lactobacillus Acidophilus.


Q: Does Lactonorm contain any animal products or gelatin?

The composition of the capsule shell or suppository base, including whether it contains ingredients like gelatin, is detailed in the excipients list within the official regulatory documents.


Q: Is Lactonorm considered a long-term solution or a temporary fix?

The standard regulatory protocol mandates a specific, short duration of treatment (e.g., 7 days). Use outside of this defined course for prolonged periods is not explicitly supported by official labeling.


Q: How does the probiotic in Lactonorm survive insertion?

The survival and efficacy of the live microorganisms are ensured by the product's specific formulation. It typically utilizes a protective matrix or specialized capsule designed to maintain bacterial viability and stability.


Q: Is it possible for Lactonorm to cause an increase in discharge?

Yes, official safety information confirms that vaginal discharge is a documented common adverse reaction. This may manifest as an increase in volume or a change in presence during treatment.


Q: Can Lactonorm be used for general vaginal wellness?

The product's officially approved use is defined by its indication, such as the restoration of microbial balance in the presence of an issue, rather than for general, non-symptomatic wellness support.


Q: What are the signs that Lactonorm is working?

The signs that the product is working generally correspond to the improvement or resolution of the symptoms related to the specific condition for which it is officially indicated and approved.


Q: Are there any foods or supplements that should be avoided while using Lactonorm?

Official regulatory documents confirm that no formal interaction restrictions are documented with food, alcohol, or herbal products while using Lactonorm.


Q: What is the shelf life of Lactonorm?

The official label specifies the product's expiration date and shelf life (e.g., in months or years) under the mandated storage conditions, which often includes refrigeration.


Q: What is the official contraindication for Lactonorm related to severe underlying diseases?

Due to the inherent risk of systemic infection from the live bacteria, the product is formally contraindicated for individuals with severe underlying diseases or who are immunocompromised (e.g., on chemotherapy).


Q: Is Lactonorm effective for all types of vaginal imbalance?

Lactonorm is approved for use against specific types of microbial imbalance. The official indication defines the particular conditions or types of imbalance for which the product's effectiveness has been clinically demonstrated and regulated.

How should Lactonorm be stored and disposed of?

Storage and Disposal Requirements for Lactonorm

The storage and disposal requirements for Lactonorm are strictly defined by regulatory documents to preserve the viability of the live microorganisms.

Storage Conditions

Lactonorm must be stored under refrigeration at a temperature between 2,^circmathrmC and 8,^circmathrmC to maintain its stability and shelf-life. The product must not be frozen. It is required to keep the medicine in its original package to protect it from light and moisture.

Child Safety and Disposal

The product must be stored out of the sight and reach of children.

Unused or expired Lactonorm should be disposed of in accordance with local regulatory requirements for pharmaceutical waste. Do not dispose of the medicine via wastewater or household trash unless directed otherwise by a drug take-back program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lactonorm found in:

A-Z Index: